Bellevue Group Ag Cidara Therapeutics, Inc. Transaction History

Bellevue Group Ag

  • $5.93 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$2.06 - $3.01 $5.81 Million - $8.5 Million
-2,822,495 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$1.74 - $4.26 $917,368 - $2.25 Million
527,223 Added 22.97%
2,822,495 $7 Million
Q2 2019

Aug 14, 2019
BUY
$1.49 - $2.94 $3.42 Million - $6.75 Million
2,295,272 New
2,295,272 $3.86 Million

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.43B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email